We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKAM icon
351
Akamai
AKAM
$16.3B
$4.25M 0.03%
47,278
-4,066
-8% -$348K
SNOW icon
352
Snowflake
SNOW
$93.7B
$4.24M 0.03%
24,079
-1,192
-5% -$194K
TRV icon
353
Travelers Companies
TRV
$82.9B
$4.22M 0.03%
24,307
-13,635
-36% -$2.4M
OXY icon
354
Occidental Petroleum
OXY
$53.6B
$4.18M 0.03%
71,015
+22,110
+45% +$1.33M
ETNB
355
DELISTED
89bio
ETNB
$4.17M 0.03%
220,000
+60,000
+38% +$1.05M
EOG icon
356
EOG Resources
EOG
$74.4B
$4.16M 0.03%
36,374
-293
-0.8% -$33.5K
BEAM icon
357
Beam Therapeutics
BEAM
$2.7B
$4.14M 0.03%
129,665
+50,000
+63% +$1.62M
WMB icon
358
Williams Companies
WMB
$85.8B
$4.11M 0.03%
125,862
SWTX
359
DELISTED
SpringWorks Therapeutics
SWTX
$3.95M 0.03%
150,626
+139,136
+1,211% +$3.66M
XRAY icon
360
Dentsply Sirona
XRAY
$2.7B
$3.9M 0.03%
97,557
+894
+0.9% +$35.5K
CCI icon
361
Crown Castle
CCI
$33.1B
$3.9M 0.03%
34,253
-22,142
-39% -$2.64M
MKC icon
362
McCormick & Company Non-Voting
MKC
$13.9B
$3.88M 0.03%
44,477
-15,616
-26% -$1.38M
WDAY icon
363
Workday
WDAY
$39.4B
$3.86M 0.03%
17,106
-6,476
-27% -$1.3M
AMP icon
364
Ameriprise Financial
AMP
$48.3B
$3.86M 0.03%
11,615
-17,316
-60% -$5.32M
EHC icon
365
Encompass Health
EHC
$11.5B
$3.79M 0.03%
56,000
+47,365
+549% +$2.97M
CARR icon
366
Carrier Global
CARR
$52.5B
$3.79M 0.03%
76,210
-43,764
-36% -$1.93M
IT icon
367
Gartner
IT
$10.4B
$3.78M 0.03%
10,803
-14,773
-58% -$4.81M
PRU icon
368
Prudential Financial
PRU
$43B
$3.75M 0.03%
42,466
-53,903
-56% -$4.51M
YUM icon
369
Yum! Brands
YUM
$41.4B
$3.74M 0.03%
26,993
+3,460
+15% +$469K
NTLA icon
370
Intellia Therapeutics
NTLA
$1.52B
$3.72M 0.03%
91,275
ABST
371
DELISTED
Absolute Software Corp
ABST
$3.7M 0.03%
+323,044
New +$3.23M
MMM icon
372
3M
MMM
$94.1B
$3.7M 0.03%
44,160
-54,270
-55% -$4.61M
KMB icon
373
Kimberly-Clark
KMB
$37.5B
$3.68M 0.03%
26,648
-20,137
-43% -$2.8M
BX icon
374
Blackstone
BX
$107B
$3.65M 0.03%
39,250
-37,388
-49% -$3.23M
WELL icon
375
Welltower
WELL
$172B
$3.62M 0.03%
44,710
-33,794
-43% -$2.6M

Similar funds

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.